Robert J. Flanagan, Director at Sagent Pharmaceuticals, Inc. (SGNT), sold 16,000 shares at $26.25 ($419K) on 2014-07-17, disclosed to the SEC on 2014-07-21.
Open-market sale of $419k SGNT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.25 | 8,000 | $210K | 50.1% |
| 2 | $26.11 | 8,000 | $209K | 49.9% |
| Total | $26.18 avg | 16,000 | $419K | 100% |
| Filing → |
| SGNT | SELL | 2014-10-08 | $505K | — | Filing → |
| SGNT | SELL | 2014-09-25 | $480K | — | Filing → |
| SGNT | SELL | 2014-09-12 | $453K | — | Filing → |